FDFatih Enes Durmaz

Fatih Enes Durmaz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Fatih Enes Durmaz has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Association of left atrioventricular coupling index with mortality in heart failure with preserved ejection fraction

    by Selda Murat, Fatih Enes Durmaz, Esra Can Onder, Halit Emre Yalvac, Bektas Murat, Yuksel Cavusoglu

    Heart failure with preserved ejection fraction (HFpEF) constitutes nearly half of all heart failure cases and represents a complex clinical syndrome characterised by impaired ventricular relaxation...

  • Open Access

    Association of Value of Fibrosis-4 Index with Long-Term Mortality in Patients with Heart Failure: A Comparison Study with Fibrosis-5 Index

    by Halit Emre Yalvaç, Fatih Enes Durmaz, Bektaş Murat, Selda Murat

    Introduction: Fibrosis-4 (FIB-4) and fibrosis-5 (FIB-5) indices are non-invasive biomarkers originally developed for hepatic fibrosis but may reflect systemic pathophysiological changes related to adverse cardiovascular prognosis. We aimed to investigate whether baseline FIB-4 and FIB-5 values predict long-term mortality in patients with heart failure (HF). Methods: This retrospective observational study included 593 patients with HF who had available long-term mortality data. FIB-4 and FIB-5 indices were calculated at admission. Patients were followed for all-cause mortality, and outcomes were evaluated at 1-year, 3-year, and 5-year intervals. Clinical, laboratory, and echocardiographic parameters were compared between survivors and non-survivors. Results: During follow-up, 1-year, 3-year, and 5-year mortality rates were 24.6%, 39.0%, and 49.7%, respectively. Non-survivors had significantly higher FIB-4 and FIB-5 values compared with survivors (P<0.001 for both). ROC curve analyses demonstrated that both indices had significant predictive performance for long-term mortality. Optimal cut-off values showed good sensitivity and specificity for identifying high-risk patients. Conclusion: Higher FIB-4 and FIB-5 values are associated with greater long-term mortality risk in HF patients. These indices may serve as practical, cost-effective prognostic biomarkers for mortality risk stratification in routine clinical care.

  • Open Access

    Preoperative Serum Albumin-to-Creatinine Ratio Predicts 1-Year Reintervention After Above-Knee Femoropopliteal Bypass Surgery

    by Mert Çelik, Arzu Funda Tarhan, Aykut Şahin, Fatih Enes Durmaz

    Objective: Serum albumin/creatinine ratio (sACR) integrates nutritional–inflammatory status and renal reserve. We evaluated its ability to predict 1-year reintervention for symptomatic graft occlusion in patients undergoing prosthetic above-knee femoropopliteal bypass for peripheral artery disease (PAD). Methods: This single-center retrospective study included 132 adults (7 women, 125 men) who underwent Dacron above-knee femoropopliteal bypass. The primary analysis evaluated preoperative sACR as a continuous variable. For descriptive comparisons and Kaplan–Meier visualization, patients were stratified according to the median preoperative sACR value (3.77), yielding two groups: p < 0.001). The optimal cutoff was ≤3.7 (sensitivity 90.9%, specificity 64.6%). Higher sACR was associated with lower 1-year event risk in both univariate and multivariate models (adjusted HR 0.61, 95% CI 0.43–0.87; p = 0.007). Conclusions: Preoperative sACR is a practical biomarker associated with early and 1-year reintervention risk after prosthetic above-knee femoropopliteal bypass and may aid perioperative risk stratification.

  • Open Access

    Intra-abdominal pressure and perfusion pressure in acute decompensated heart failure: clinical and prognostic insights

    by Selda Murat, Fatih Enes Durmaz, Ahmet Sekip Ahmadi, Zeynep Yuzuak, Bektas Murat, Yuksel Cavusoglu

    Background: Abdominal venous congestion is increasingly recognized as an important contributor to clinical deterioration in acute decompensated heart failure (ADHF). Intra-abdominal pressure (IAP) and abdominal perfusion pressure (APP) may provide complementary insights into systemic congestion and organ perfusion; however, their prognostic value in ADHF remains undefined. Aim: To evaluate the prognostic value of IAP and APP in patients with acute decompensated heart failure. Methods: This prospective observational study enrolled 110 consecutive patients hospitalized with ADHF. IAP was measured using a standardized transvesical technique within the first 24 h of admission, and intra-abdominal hypertension (IAH) was defined as an IAP ≥ 12 mmHg. APP was calculated as mean arterial pressure minus IAP. Clinical, echocardiographic, and laboratory characteristics were recorded. Mortality and rehospitalization at 1, 6, and 12 months were assessed, and multivariable regression analyses were performed to identify independent predictors of adverse outcomes. Results: IAH was present in 29.1% of patients. Compared with patients without IAH, those with IAH had lower diastolic and mean arterial pressures, larger right atrial dimensions, and worse renal function. Elevated IAP was associated with significantly higher mortality at 1, 6, and 12 months, as well as increased rehospitalization rates during follow-up. In multivariable analyses, elevated IAP remained an independent predictor of mortality and rehospitalization, whereas higher APP was associated with more favorable early outcomes. Conclusion: Elevated IAP is an independent predictor of adverse outcomes in ADHF, while APP provides complementary prognostic information. Integrating both congestion- and perfusion-related parameters may improve risk stratification and guide targeted decongestive strategies.

  • Long-Term Prognosis of Acute Myocardial Infarction Caused by Isolated Diffuse Coronary Artery Ectasia

    by Adnan Abaci, Murat Gökhan Yerlikaya, Tuğba Kapanşahin, Göktuğ Savaş, Ali Riza Akyüz, Şükriye Uslu, Muhammed Esad Çekin, Ayşe Hoşoğlu, Ali Bağci, Abdulsamet Arslan, et al.

    BACKGROUND: Isolated coronary artery ectasia (CAE) is a less common form of CAE. The clinical significance of isolated CAE has not been elucidated yet. We aimed to compare the patients with myocardial infarction (MI) due to isolated CAE with the patients without CAE. METHODS: We retrospectively included patients who underwent coronary angiography with a diagnosis of first MI caused by isolated CAE. We excluded patients with >20% stenosis in any vessel other than the lesion responsible for the MI. A second group of patients with MI without CAE was selected as the control group. The primary outcome was the composite of all-cause death and nonfatal recurrent MI occurring after index hospitalization. RESULTS: A total of 404 patients were included. Overall, 63.9% of MIs were ST-elevation MI. Almost all patients in the isolated CAE group had multivessel diffuse ectasia, with 71.3% classified as Markis I, and 26.7% as Markis II. Death or MI recurrence occurred in 54 (26.7%) patients in the isolated CAE group and 33 (16.3%) patients in the control group ( P =0.011). Death occurred in 8 (4.0%) patients in the isolated CAE group versus 6 (3.0%) patients in the control group; recurrent MI in 46 (22.8%) versus 27 (13.4%) patients, respectively. Stent thrombosis was more common in the CAE group compared with the control group (8.9% versus 1.5%; P P =0.017), and recurrent MI (hazard ratio, 2.07 [95% CI, 1.08–3.96]; P =0.029). CONCLUSIONS: The patients with MI due to isolated CAE had a higher risk of recurrent MI and stent thrombosis compared with the patients without CAE. In this study, the rate of recurrent MI from the index infarct artery was also higher in the patients with CAE.


  • Impact of Disease Duration on Left Atrial Function in Patients with Graves’ Disease

    by Selda Murat, Fatih Enes Durmaz, Birsen Ozturk Gokce, Elif Seray Korkmaz, Ezgi Demirtas, Bektas Murat, Goknur Yorulmaz, Aysen Akalın, Yuksel Cavusoglu

    Introduction: Graves’ disease is associated with cardiovascular alterations. Data on the left ventricular (LV) function and left atrial (LA) mechanics in Graves’ disease remain limited. This study investigated the relationship between disease duration and myocardial deformation parameters, including LA strain and LV global longitudinal strain (LV-GLS). Methods: In this cross-sectional study, 90 patients with Graves’ disease underwent comprehensive echocardiographic assessment. Disease duration was classified as short (≤2 years) or long (>2 years) based on receiver operating characteristic analysis. LA reservoir strain (LASr), conduit strain (LAScd), contractile strain (LASct), and LV-GLS were measured. In addition, strain parameters were compared between patients according to thyroid status (euthyroid vs. hyperthyroid). Results: Patients with longer disease duration showed significantly reduced LASr (36.9 ± 12.0% vs. 46.3 ± 11.0%, p = 0.001), LAScd (−20.2 ± 9.3% vs. −26.3 ± 9.4%, p = 0.007), LASct (−17.0 ± 6.4% vs. −19.9 ± 5.9%, p = 0.045), and absolute LV-GLS (20.8% [18.4%–24.9%] vs. 24.3% [21.7%–27.4%], p = 0.007). Disease duration correlated negatively with LASr (r = −0.340, p < 0.001) and absolute LV-GLS (r = −0.311, p = 0.003). Multivariate analysis identified LASr (OR = 0.947, p = 0.017) and LV-GLS (OR = 0.838, p = 0.020) as independent predictors of prolonged disease duration. In euthyroid patients with longer disease duration, strain parameters were significantly lower than in hyperthyroid patients with shorter duration. Conclusion: Longer Graves’ disease duration is associated with progressive subclinical impairment of atrial and ventricular mechanics, with strain abnormalities evident even in euthyroid patients. These findings highlight the cumulative impact of disease chronicity and support the use of speckle-tracking echocardiography for early detection of myocardial dysfunction and closer cardiovascular monitoring in this population.

  • Open Access

    Associação do Valor Pan-Imune-Inflamatório com Desfechos de Longo Prazo na Insuficiência Cardíaca Agudamente Descompensada

    by Bektas Murat, Selda Murat, Mehmet Eren Altınbas, Halit Emre Yalvac, Fatih Enes Durmaz, Kadir Ugur Mert, Yüksel Cavusoglu

    Resumo Fundamento Embora tenha havido melhorias significativas no tratamento da insuficiência cardíaca (IC) nas últimas décadas, seu prognóstico permanece desfavorável. Embora existam muitos biomarcadores que podem ajudar a prever o prognóstico de pacientes com IC, há necessidade de biomarcadores mais simples, menos dispendiosos e mais facilmente disponíveis. Objetivo Avaliar o valor preditivo do valor pan-imune-inflamatório (PIV, do inglês pan-immune-inflammation value) em pacientes com IC agudamente descompensada. Métodos Analisamos 409 pacientes com IC com fração de ejeção reduzida internados por IC aguda descompensada. Os pacientes foram divididos em 3 grupos de acordo com os tercis de PIV: tercil 1 (PIV < 357,25), tercil 2 (PIV ≥ 357,25 e < 834,55) e tercil 3 (PIV ≥ 834,55). Foram considerados estatisticamente significativos valores de p < 0,05. Curvas de Kaplan-Meier e modelos de regressão de riscos proporcionais de Cox foram utilizados para avaliar a associação entre PIV e mortalidade por todas as causas. O desfecho primário foi mortalidade por todas as causas em 5 anos, e o desfecho secundário compreendeu a mortalidade por todas as causas intra-hospitalar em 30 dias, em 180 dias e em 1 ano Resultados Mostramos que valores mais elevados de PIV estavam associados a desfechos primários e secundários. A curva de Kaplan-Meier mostrou que pacientes com valores mais elevados de PIV apresentaram risco aumentado de mortalidade por todas as causas em curto e longo prazo (log-rank p < 0,001). Na análise multivariada, o PIV foi identificado como um preditor independente de mortalidade por todas as causas em longo prazo em pacientes com IC aguda descompensada, e observamos um aumento de 1,96 vezes no risco de um evento (razão de chances: 1,96; intervalo de confiança de 95%: 1,330 a 2,908; p = 0,001). Conclusões Nosso estudo mostrou que o novo biomarcador PIV pode ser usado como preditor de prognóstico em pacientes com IC aguda descompensada.